Estimates Revisions Unicycive Therapeutics, Inc.
Stocks
UNCY
US90466Y2028
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.250 USD | -5.72% |
|
+4.77% | +25.65% |
| 06-05 | Unicycive Therapeutics Raises ATM Offering of Shares | MT |
| 05-12 | Unicycive Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- UNCY Stock
- Consensus Unicycive Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
